Stock APDN APPLIED DNA SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Applied DNA Sciences, Inc.

Equities

APDN

US03815U4094

Market Closed - Nasdaq
Other stock markets
 02:00:00 15/05/2024 am IST 		5-day change 1st Jan Change
3.22 USD +4.55% Intraday chart for Applied DNA Sciences, Inc. -10.56% -73.90%
14/05 Maxim Downgrades Applied DNA Sciences to Hold From Buy MT
13/05 Top Premarket Decliners MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Top Premarket Decliners
Applied DNA Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024
Applied DNA Sciences Regains Nasdaq Minimum Bid Price Requirement
Banned Chinese cotton found in 19% of US retailers' merchandise, study shows
Applied DNA Sciences, Inc. Receives Contract by HDT Bio for Rapid Vaccine Development Program
Applied DNA Sciences, Inc. to Showcase Linea DNA and Linea IVT Platforms At 24Th Annual World Vaccine Congress
Applied DNA Sciences Files Prospectus for Potential Secondary Stock Offerings
Applied DNA Sciences, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023
Applied DNA Sciences, Inc. Announces Joint Development Agreement to Integrate Linea IVT Platform into CDMO Kudo Biotechnology?s mRNA Manufacturing Workflow
Applied DNA Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended September 30, 2023
Applied DNA Sciences, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023
Applied DNA Sciences, Inc. Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application
Applied DNA Sciences, Inc. Extends Application of Linea(Tm) Ivt Platform to Sna (Self-Amplifying Mrna)
Applied DNA Sciences, Inc. Advances Commercialization of Linea(TM) IVT Platform
Applied DNA Sciences, Inc. Announces Appointment of Beverly Wolgast as Executive Director of Quality and cGMP Programs
Applied DNA Sciences, Inc. Announces Availability and First Customer Shipment of New Linea(TM) IVT Evaluation Kit
Applied DNA Sciences Files Patent Applications for mRNA Production by Reducing Double-Stranded RNA
Applied DNA Sciences, Inc. Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Generation mRNA Production
Applied DNA Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023
Applied Dna Sciences, Inc. Announces That Scott L. Anchin Will Not Stand for Re-Election as Director
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. APDN Stock
  4. News Applied DNA Sciences, Inc.
  5. Other languages
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW